Skip to content

To see the effect of local application of Arthocan-C25 tail in Rheaumatoid Arthritis

A Pilot Exploratory Clinical Study To Evaluate The Efficacy of local Application of Arthocan-C25 Tail in Rheumatoid Arthritis (Aamvata) - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075256
Enrollment
30
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

SUDHATATVA Pharmacy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having inflammation of joint [Sandhi shoth] 1.Joint pain[sandhishool] 2.Restriction of joint movements [Sandhigraha] 3.Tenderness [Sparsha asahatva]

Exclusion criteria

Exclusion criteria: 1)Individuals with known case of uncontrolled diabetes mellitus. 2)Known case of vatarakta and Sandhigat vata. 3)Known case of Ankylosing Spondylosis

Design outcomes

Primary

MeasureTime frame
Reduction in inflammation of joint (Sandhishotha) using measuring tape before and after treatment of local application Arthocan -C25 oil. Timepoint: 14 days

Secondary

MeasureTime frame
Reduction in Joint Pain (Sandhishoola) using the VAS scale before and after treatment of Local application of Arthocan- C25 oil. Timepoint: 14 days

Countries

India

Contacts

Public ContactDr Vaishali Chaudhari

Dr D Y Patil College Of Ayurved And Research Centre

vaishali.chaudhari@dpu.edu.in9822964710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026